China Biotech Strikes Record Number of Licensing Deals
Chinese biotech firms have struck a record number of deals to license their products overseas,FT reports.
As of August, Chinese companies have
Record Chinese biotech licensing deals amidst gradual shift to NewCo model; China leading in European plug-in hybrids sales while industry lobbies for hybrids; and Saudi Arabia goes all-out to attract Chinese tech investment and expats

Chinese biotech firms have struck a record number of deals to license their products overseas,FT reports.
As of August, Chinese companies have
Subscribe to China Law & Practice today for:
Already a Subscriber? Log In. Sign In Now
Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)